The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells

[1]  A. Bøyum,et al.  Separation of blood leucocytes, granulocytes and lymphocytes. , 2008, Tissue antigens.

[2]  T. Ebina,et al.  Antitumor Effector Mechanism at a Distant Site in the Double Grafted Tumor System of PSK, a Protein‐bound Polysaccharide Preparation , 1988, Japanese journal of cancer research : Gann.

[3]  T. Yamaguchi,et al.  Antimetastatic effect of biological response modifiers in the "double grafted tumor system". , 1986, Japanese journal of cancer research : Gann.

[4]  P. Schlag,et al.  Chemosensitivity testing of human neoplasms using the soft agar colony assay. , 1984, Cancer treatment reviews.

[5]  G. Klein,et al.  Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course , 1983, Cancer Immunology, Immunotherapy.

[6]  G. Klein,et al.  Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course , 1983, Cancer Immunology, Immunotherapy.

[7]  S. Argov,et al.  Tumor biopsy cells participating in systems in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies , 1981, International journal of cancer.

[8]  E. Saksela,et al.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. , 1979, Cellular immunology.

[9]  M. Kondo,et al.  Activation of the complement by immunostimulants, BCG, OK-432 (Picibanil), and PS-K (Krestin) in vitro. , 1978, Gan.

[10]  E. Klein,et al.  Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans , 1977, International journal of cancer.

[11]  S. Tsukagoshi,et al.  Protein-bound polysaccharide preparation, PS-K, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use. , 1974, Gan.

[12]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.

[13]  R. Kumashiro,et al.  Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach , 2006, The Japanese journal of surgery.

[14]  E. Klein,et al.  Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K , 2005, Cancer Immunology, Immunotherapy.

[15]  E. Klein,et al.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro , 2005, Cancer Immunology, Immunotherapy.

[16]  E. Klein,et al.  Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells , 2004, Cancer Immunology, Immunotherapy.

[17]  T. Ivert,et al.  Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery , 2004, Cancer Immunology, Immunotherapy.

[18]  P. Greenberg.  Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.

[19]  T. Ivert,et al.  Recognition of Autologous Tumour Cells by Blood Lymphocytes in Patients with Lung Cancer , 1987 .

[20]  T. Taguchi.  Clinical studies on PSK: combination therapy of PSK with surgery and chemotherapy. , 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[21]  J. Stjernswärd,et al.  LYMPHOCYTE STIMULATION TEST FOR DETECTION OF TUMOR SPECIFIC REACTIVITY IN HUMANS , 1976 .